Impact of Anti-CD20 therapies on the immune homeostasis of gastrointestinal mucosa and their relationship with de novo intestinal bowel disease in multiple sclerosis: a review

Impact of Anti-CD20 therapies on the immune homeostasis of gastrointestinal mucosa and their relationship with de novo intestinal bowel disease in multiple sclerosis: a review

Multiple sclerosis (MS) and inflammatory bowel disease (IBD) are autoimmune disorders characterized by inflammatory episodes affecting the brain and the gastrointestinal (GI) tract, respectively. The frequent association between MS and IBD suggests that both conditions may share common pathogenic me...

Full description

Bibliographic Details
Main Authors: A. Quesada-Simó, A. Garrido-Marín, P. Nos, S. Gil-Perotín
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Pharmacology
Subjects:
ocrelizumab
rituximab
ulcerative colitis
crohn’s disease
microscopic colitis
anti-S1P
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1186016/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1186016/full

Similar Items